You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

List of Excipients in API naproxen sodium tablet


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing naproxen sodium tablet

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Lil' Drug Store Products Inc ALEVE naproxen sodium tablet 29485-6751 ALUMINUM OXIDE
Lil' Drug Store Products Inc ALEVE naproxen sodium tablet 29485-6751 CELLULOSE, MICROCRYSTALLINE
Lil' Drug Store Products Inc ALEVE naproxen sodium tablet 29485-6751 FD&C BLUE NO. 2
Lil' Drug Store Products Inc ALEVE naproxen sodium tablet 29485-6751 HYPROMELLOSE
Lil' Drug Store Products Inc ALEVE naproxen sodium tablet 29485-6751 MAGNESIUM STEARATE
Lil' Drug Store Products Inc ALEVE naproxen sodium tablet 29485-6751 POLYETHYLENE GLYCOL
Lil' Drug Store Products Inc ALEVE naproxen sodium tablet 29485-6751 POVIDONE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing naproxen sodium tablet

Company Ingredient NDC Excipient
MARKSANS PHARMA LIMITED naproxen sodium tablet, coated 25000-144 CELLULOSE, MICROCRYSTALLINE
MARKSANS PHARMA LIMITED naproxen sodium tablet, coated 25000-144 CROSCARMELLOSE SODIUM
MARKSANS PHARMA LIMITED naproxen sodium tablet, coated 25000-144 FD&C BLUE NO. 2
MARKSANS PHARMA LIMITED naproxen sodium tablet, coated 25000-144 HYPROMELLOSES
MARKSANS PHARMA LIMITED naproxen sodium tablet, coated 25000-144 MAGNESIUM STEARATE
MARKSANS PHARMA LIMITED naproxen sodium tablet, coated 25000-144 POLYETHYLENE GLYCOL
MARKSANS PHARMA LIMITED naproxen sodium tablet, coated 25000-144 POVIDONE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for naproxen sodium tablet

Excipient focus: ALUMINUM OXIDE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

naproxen sodium tablet drug variants containing CELLULOSE, MICROCRYSTALLINE

Company Ingredient NDC
Lil' Drug Store Products Inc naproxen sodium tablet 29485-6751
Lil' Drug Store Products Inc naproxen sodium tablet 66715-5103
MARKSANS PHARMA LIMITED naproxen sodium tablet, coated 25000-144
HealthLife of USA LLC naproxen sodium tablets, 220 mg 69517-109
We Care Distributor Inc naproxen sodium tablets, 220 mg 70005-008
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: FD&C BLUE NO. 2

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSES

Excipient focus: MAGNESIUM STEARATE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links